Global Health Progress

Research-based biopharmaceutical companies work in partnership with others to fight the malaria epidemic
Despite being preventable and treatable, malaria continues to devastate communities in tropical regions throughout Latin America, Asia and Africa. According to the World Health Organization (WHO), the malaria epidemic causes debilitating disease in more than 500 million people worldwide and kills more than [...]

Malaria kills nearly a million people annually. Every 30 seconds, an African child dies as a result of malaria infection. With 350 to 500 million illnesses and more than one million deaths annually, it’s a disease that wreaks havoc on families and communities and devastates national economies. In short, it is one of the greatest threats to global health and economic welfare.

Industry supports hundreds of programs helping millions in the developing
world and is looking for new partners
The worldwide pharmaceutical industry today launched Global Health Progress, an initiative to bring research-based biopharmaceutical companies, global health leaders and policymakers together to build on current partnerships to improve health in the developing world.
Read the release >>

We are still losing the fight against AIDS, badly. But there are good reasons to think we can win, with the tool that holds the hope of eliminating, and not just curbing the epidemic: a preventive vaccine.

Industry supports hundreds of programs helping millions in the developing world and is looking for new partners
The worldwide pharmaceutical industry today launched Global Health Progress, an initiative to bring research-based biopharmaceutical companies, global health leaders and policymakers together to build on current partnerships to improve health in the developing world.
Serving as a convening point for [...]